Stockreport

BriaCell’s Phase 3 Patient Enrollment on Track for 1H2026 Topline Data Readout

BriaCell Therapeutics Corp. - Common Shares  (BCTX) 
PDF Over 230 patients screened and over 160 patients enrolled in BriaCell’s pivotal Phase 3 study in metastatic breast cancer (MBC)Enrollment exceeding expectations with str [Read more]